Total Anomalous Pulmonary Venous Connection (TAPVC) is a rare congenital heart defect characterized by an abnormal connection of all pulmonary veins to systemic venous vessels, preventing oxygenated blood from directly reaching the left atrium. This condition leads to a severe disruption of neonatal hemodynamics, with severe hypoxemia and right heart volume overload, requiring urgent intervention to ensure survival.
TAPVC accounts for approximately 1–2% of all congenital heart diseases, with an estimated incidence of 1 in every 15,000 live births. Although it shares many similarities with Total Anomalous Pulmonary Venous Return (TAPVR), it differs due to the presence of interposed anomalous venous pathways between the pulmonary veins and the systemic circulation, rather than a direct connection to systemic venous structures. The main differences between these two entities are summarized in the comparative table at the bottom of the page.
Neonatal survival depends on the presence of compensatory shunts that allow minimal passage of oxygenated blood into the systemic circulation. Two critical elements are:
Without these communications, the condition rapidly progresses to metabolic acidosis, hypoxic shock, and early neonatal death. Prompt identification is therefore crucial to initiate life-saving treatment.
Under normal conditions, the four pulmonary veins drain oxygenated blood from the lungs directly into the left atrium, from where it continues into the systemic circulation. In TAPVC, this connection is absent, and the pulmonary veins join into a common venous confluence that does not reach the left atrium, but instead drains into systemic venous structures through interposed anomalous vessels.
Anatomical classification of TAPVC is based on the point at which oxygenated blood enters the systemic circulation:
A typical complication of TAPVC is pulmonary venous obstruction, which is more frequent than in classic TAPVR, especially in infracardiac forms. The passage of blood through long, tortuous, and narrow venous channels that traverse structures such as the diaphragm or are compressed between other organs creates a high pressure gradient between the pulmonary capillary bed and the systemic outflow point. This mechanism results in a severe pulmonary hypertension profile, leading to interstitial edema, reduced pulmonary compliance, increased respiratory effort, and refractory hypoxemia.
The right heart is exposed to a chronic volume overload as it receives both the systemic venous return and the entire oxygenated pulmonary flow. Progressive hypertrophy of the right chambers, combined with pulmonary hypertension, can rapidly result in congestive heart failure, causing multiorgan dysfunction in untreated neonates.
The clinical presentation of Total Anomalous Pulmonary Venous Connection (TAPVC) depends primarily on two factors: the presence of venous return obstruction and the adequacy of compensatory shunts (PDA and ASD). In obstructed forms, symptoms appear within the first hours of life, whereas in unobstructed cases, the onset may be more insidious.
In neonates with obstruction, the clinical picture is dramatic:
Conversely, in non-obstructive forms, neonates may present with mild to moderate cyanosis, moderate tachypnea, and progressive symptoms of pulmonary congestion during the first days or weeks of life. The physical examination may reveal cardiomegaly, functional murmurs, accentuated heart sounds, and signs of pulmonary overcirculation on auscultation.